These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17052186)

  • 1. Molecular misreading: the occurrence of frameshift proteins in different diseases.
    van Leeuwen FW; Kros JM; Kamphorst W; van Schravendijk C; de Vos RA
    Biochem Soc Trans; 2006 Nov; 34(Pt 5):738-42. PubMed ID: 17052186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational diseases: an umbrella for various neurological disorders with an impaired ubiquitin-proteasome system.
    de Pril R; Fischer DF; van Leeuwen FW
    Neurobiol Aging; 2006 Apr; 27(4):515-23. PubMed ID: 16226348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frameshift proteins in Alzheimer's disease and in other conformational disorders: time for the ubiquitin-proteasome system.
    van Leeuwen FW; Hol EM; Fischer DF
    J Alzheimers Dis; 2006; 9(3 Suppl):319-25. PubMed ID: 16914870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term proteasome dysfunction in the mouse brain by expression of aberrant ubiquitin.
    Fischer DF; van Dijk R; van Tijn P; Hobo B; Verhage MC; van der Schors RC; Li KW; van Minnen J; Hol EM; van Leeuwen FW
    Neurobiol Aging; 2009 Jun; 30(6):847-63. PubMed ID: 18760506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Misframed proteins and neurodegeneration: a novel view on Alzheimer's and Parkinson's diseases.
    Dennissen FJ; Kholod N; Steinbusch HW; Van Leeuwen FW
    Neurodegener Dis; 2010; 7(1-3):76-9. PubMed ID: 20173331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low levels of mutant ubiquitin are degraded by the proteasome in vivo.
    van Tijn P; Verhage MC; Hobo B; van Leeuwen FW; Fischer DF
    J Neurosci Res; 2010 Aug; 88(11):2325-37. PubMed ID: 20336771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease-specific accumulation of mutant ubiquitin as a marker for proteasomal dysfunction in the brain.
    Fischer DF; De Vos RA; Van Dijk R; De Vrij FM; Proper EA; Sonnemans MA; Verhage MC; Sluijs JA; Hobo B; Zouambia M; Steur EN; Kamphorst W; Hol EM; Van Leeuwen FW
    FASEB J; 2003 Nov; 17(14):2014-24. PubMed ID: 14597671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of frameshift ubiquitin B protein in Alzheimer's disease.
    Chen X; Petranovic D
    Wiley Interdiscip Rev Syst Biol Med; 2016 Jul; 8(4):300-13. PubMed ID: 27240056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases.
    Ross CA; Pickart CM
    Trends Cell Biol; 2004 Dec; 14(12):703-11. PubMed ID: 15564047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease-associated mutant ubiquitin causes proteasomal impairment and enhances the toxicity of protein aggregates.
    Tank EM; True HL
    PLoS Genet; 2009 Feb; 5(2):e1000382. PubMed ID: 19214209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proteasome in Alzheimer's disease and Parkinson's disease: lessons from ubiquitin B+1.
    Hol EM; van Leeuwen FW; Fischer DF
    Trends Mol Med; 2005 Nov; 11(11):488-95. PubMed ID: 16213790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal length requirement for proteasomal degradation of ubiquitin-dependent substrates.
    Verhoef LG; Heinen C; Selivanova A; Halff EF; Salomons FA; Dantuma NP
    FASEB J; 2009 Jan; 23(1):123-33. PubMed ID: 18796559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteasome subunit proteins and neuropathology in tauopathies and synucleinopathies: Consequences for proteomic analyses.
    Zouambia M; Fischer DF; Hobo B; De Vos RA; Hol EM; Varndell IM; Sheppard PW; Van Leeuwen FW
    Proteomics; 2008 Mar; 8(6):1221-36. PubMed ID: 18283660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent inhibition of proteasome activity by a mutant ubiquitin associated with neurodegenerative disease.
    van Tijn P; de Vrij FM; Schuurman KG; Dantuma NP; Fischer DF; van Leeuwen FW; Hol EM
    J Cell Sci; 2007 May; 120(Pt 9):1615-23. PubMed ID: 17405812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review: unchained maladie - a reassessment of the role of Ubb(+1) -capped polyubiquitin chains in Alzheimer's disease.
    Chadwick L; Gentle L; Strachan J; Layfield R
    Neuropathol Appl Neurobiol; 2012 Apr; 38(2):118-31. PubMed ID: 22082077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant ubiquitin expressed in Alzheimer's disease causes neuronal death.
    De Vrij FM; Sluijs JA; Gregori L; Fischer DF; Hermens WT; Goldgaber D; Verhaagen J; Van Leeuwen FW; Hol EM
    FASEB J; 2001 Dec; 15(14):2680-8. PubMed ID: 11726544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term proteasomal inhibition in transgenic mice by UBB(+1) expression results in dysfunction of central respiration control reminiscent of brainstem neuropathology in Alzheimer patients.
    Irmler M; Gentier RJ; Dennissen FJ; Schulz H; Bolle I; Hölter SM; Kallnik M; Cheng JJ; Klingenspor M; Rozman J; Ehrhardt N; Hermes DJ; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Meyer HE; Hopkins DA; Van Leeuwen FW; Beckers J
    Acta Neuropathol; 2012 Aug; 124(2):187-97. PubMed ID: 22730000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggresome formation in liver cells in response to different toxic mechanisms: role of the ubiquitin-proteasome pathway and the frameshift mutant of ubiquitin.
    French BA; van Leeuwen F; Riley NE; Yuan QX; Bardag-Gorce F; Gaal K; Lue YH; Marceau N; French SW
    Exp Mol Pathol; 2001 Dec; 71(3):241-6. PubMed ID: 11733949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global changes to the ubiquitin system in Huntington's disease.
    Bennett EJ; Shaler TA; Woodman B; Ryu KY; Zaitseva TS; Becker CH; Bates GP; Schulman H; Kopito RR
    Nature; 2007 Aug; 448(7154):704-8. PubMed ID: 17687326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications.
    Williams A; Jahreiss L; Sarkar S; Saiki S; Menzies FM; Ravikumar B; Rubinsztein DC
    Curr Top Dev Biol; 2006; 76():89-101. PubMed ID: 17118264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.